[1]
Md Shams Tabrez1, Ravi Kumar2, Veena Kumari3*, “Renal and Glycemic Outcomes with Linagliptin versus Vildagliptin as Add-On Therapy in Uncontrolled Type 2 Diabetes Mellitus: A Prospective Observational Study”, IJMSCRR, vol. 9, no. 04, pp. Page: 897–910, Aug. 2026.